Skip to main content
Mithra Pharmaceuticals S.A. logo

Mithra Pharmaceuticals S.A. — Investor Relations & Filings

Ticker · MITRA ISIN · BE0974283153 LEI · 5493002FDD273HTEKK14 BR Manufacturing
Open in API
Filings indexed 754 across all filing types
Latest filing 2023-11-06 Proxy Solicitation & In…
Country BE Belgium
Listing BR MITRA

About Mithra Pharmaceuticals S.A.

https://www.mithra.com/

Mithra Pharmaceuticals S.A. is a biotech company dedicated to women's health. The company focuses on the development, manufacturing, and commercialization of differentiated drugs and complex therapeutic solutions. Its core areas of expertise include contraception, fertility, and menopause. Mithra aims to transform the women's health sector by providing innovative choices to support and improve the overall quality of life for women.

Recent filings

Filing Released Lang Actions
2023-11-06_MITHRA_EGM-NOVEMBER-2023_VOTING-BY-MAIL_EN.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Voting by Mail' form for an Extraordinary General Meeting (EGM) of Mithra Pharmaceuticals SA. It contains the agenda, proposed resolutions regarding capital increases, and instructions for shareholders to cast their votes. This material is provided to shareholders to inform them of meeting items and to solicit their votes, which fits the definition of a Proxy Solicitation & Information Statement.
2023-11-06 English
2023-11-06_MITHRA_EGM-NOVEMBER-2023_VOTING-BY-MAIL_FR.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Vote par correspondance' (Proxy Voting Form) for an Extraordinary General Meeting (EGM) of Mithra Pharmaceuticals SA. It contains the agenda for the meeting, including proposals for capital increases and renewals of board authorizations, and provides shareholders with the necessary information and a form to cast their votes. This falls under the category of Proxy Solicitation & Information Statement (PSI), as it is a document sent to shareholders to provide information and request votes for a meeting.
2023-11-06 French
2023-11-06_MITHRA_EGM-NOVEMBER-2023_CONVENING-NOTICE_EN.pdf
AGM Information Classification · 98% confidence The document is a 'Convening Notice to Attend the Extraordinary General Meeting of Shareholders'. It outlines the agenda, proposed resolutions, and specific items for shareholder voting, such as the renewal of authorized capital and capital increases. This document is a formal solicitation of shareholder action and information for an upcoming meeting, which falls under the definition of a Proxy Solicitation & Information Statement.
2023-11-06 English
2023-11-06_MITHRA_EGM-NOVEMBER-2023_CONVENING-NOTICE_FR.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Convocation à l'Assemblée Générale Extraordinaire' (Notice of Extraordinary General Meeting) for Mithra Pharmaceuticals SA. It outlines the agenda, proposed resolutions, and specific items for shareholder voting, such as the renewal of authorized capital and capital increases. This document is provided to shareholders to inform them of the meeting and solicit their votes, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2023-11-06 French
Statutory Auditor Report - HB_WB Facility Amendment (FR) - Executed.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a formal report by an auditor (commissaire) regarding a capital increase through a contribution in kind (apport en nature) for Mithra Pharmaceuticals SA. It explicitly references Articles 7:197 and 7:179 of the Belgian Code of Companies and Associations, which mandate an auditor's report to evaluate the board's proposal for capital increases. This is a standalone audit-related report concerning specific corporate financial transactions, fitting the definition of an Audit Report/Information.
2023-11-06 French
Annexe A - Conditions of the Warrants (ENG).pdf
Capital/Financing Update Classification · 98% confidence The document is a legal contract titled '2023 INVESTOR WARRANTS TERMS AND CONDITIONS' issued by Mithra Pharmaceuticals. It details the specific terms, exercise price, expiration, and definitions related to the issuance of subscription rights (warrants) to investors. This document falls under the category of capital structure and financing updates, as it outlines the terms of a financial instrument (warrants) issued by the company to raise or manage capital.
2023-11-06 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.